High-Density Lipoprotein Nanoparticles Deliver RNAi to Endothelial Cells to Inhibit Angiogenesis

Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles

(2015) Mian M.K. Shahzad et al.   NEOPLASIA

Anti-angiogenesis in cancer therapy: Hercules and hydra

(2013) S. Bellou et al.   CANCER LETTERS

Lipid-based nanoparticles in the systemic delivery of siRNA

(2013) Qiaoya Lin et al.   Nanomedicine

Cardiovascular complications associated with novel angiogenesis inhibitors: Emerging evidence and evolving perspectives

(2013) Steven M. Bair et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Efficient systemic delivery of siRNA by using high-density lipoprotein-mimicking peptide lipid nanoparticles

(2012) Qiaoya Lin et al.   Nanomedicine

Third Generation Tyrosine Kinase Inhibitors and Their Development in Advanced Renal Cell Carcinoma

(2012) Ronald M. Bukowski   Frontiers in Oncology

Scavenger receptor class B type I: a multifunctional receptor

(2011) Giuseppe Valacchi et al.   Annals of the New York Academy of Sciences

The use of bevacizumab among women with metastatic breast cancer: A survey on clinical practice and the ongoing controversy

(2011) Shaheenah Dawood et al.   CANCER

Targeting Tumor-Associated Endothelial Cells: Anti-VEGFR2 Immunoliposomes Mediate Tumor Vessel Disruption and Inhibit Tumor Growth

(2011) A. Wicki et al.   CLINICAL CANCER RESEARCH

Biomimetic High Density Lipoprotein Nanoparticles For Nucleic Acid Delivery

(2011) Kaylin M. McMahon et al.   NANO LETTERS

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

(2011) Kasey C. Vickers et al.   NATURE CELL BIOLOGY

Current prospects for RNA interference-based therapies

(2011) Beverly L. Davidson et al.   NATURE REVIEWS GENETICS

Cardiovascular toxicity of anti-angiogenic drugs

(2011) Gaetan des Guetz et al.   Targeted Oncology

Erratum: Knocking down barriers: advances in siRNA delivery

(2010) Kathryn A. Whitehead et al.   NATURE REVIEWS DRUG DISCOVERY

Safety Implications of Vascular Endothelial Growth Factor Blockade for Subjects Receiving Intravitreal Anti–Vascular Endothelial Growth Factor Therapies

(2009) Karl Csaky et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

High-Density Lipoprotein Transport Through Aortic Endothelial Cells Involves Scavenger Receptor BI and ATP-Binding Cassette Transporter G1

(2009) Lucia Rohrer et al.   CIRCULATION RESEARCH

VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management

(2009) Hassane Izzedine et al.   EUROPEAN JOURNAL OF CANCER

Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier

(2009) Linda K. Mooberry et al.   JOURNAL OF DRUG TARGETING

Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts

(2009) C. L. Roland et al.   MOLECULAR CANCER THERAPEUTICS

HDL-Mimicking Peptide-Lipid Nanoparticles with Improved Tumor Targeting

(2009) Zhihong Zhang et al.   Small

Normal Hepatic Cell Surface Localization of the High Density Lipoprotein Receptor, Scavenger Receptor Class B, Type I, Depends on All Four PDZ Domains of PDZK1

(2008) Sara A. Fenske et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Recombinant high-density lipoprotein complex as a targeting system of nosiheptide to liver cells

(2008) Meiqing Feng et al.   JOURNAL OF DRUG TARGETING